Home

Jenburkt Pharmaceuticals Ltd Board of Directors

Board of Directors at Jenburkt Pharmaceuticals Ltd

Ashish Shah

Company Sec. & Compli. Officer

Ashish Bhuta

Chairman & Managing Director

Dilip Bhuta

Whole Time Director & CFO

Hina Mehta

Non-Exec. & Independent Dir.

KRISHNAN SUBHARAMAN

Independent Director

Key Highlights

  • Ashish R Shah continues to serve as the Company Sec. & Compli. Officer in 2024, maintaining the same position as in the previous year.
  • Ashish U Bhuta continues to serve as the Chairman & Managing Director in 2024, maintaining the same position as in the previous year.
  • Dilip H Bhuta joins the board as Whole Time Director & CFO, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
  • Hina Ravindra Mehta joins the board as Non-Exec. & Independent Dir., in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
  • Sumit Ajaybhai Thakkar joins the board as Independent Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Image

Jenburkt Pharmaceuticals Ltd

NSE: JENBURKTPHARMA

Share Price

-

-

stock direction

Last updated on:

Last Ten Days Market Price

Date
leftPrice (₹)right
27 Dec 20241187
26 Dec 20241201.05
24 Dec 20241213.55
23 Dec 20241218
20 Dec 20241242.4
19 Dec 20241290.5
18 Dec 20241314.7
17 Dec 20241326.7
16 Dec 20241303.7
13 Dec 20241312.3

Company Fundamentals for Jenburkt Pharmaceuticals Ltd

Market Cap

523 Cr

EPS

68.7

P/E Ratio (TTM)

17.3

P/B Ratio (TTM)

3.3

Day’s High

1220.0

Day’s Low

1179.95

DTE

0.0

ROE

19.2

52 Week High

1375.0

52 Week Low

660.05

ROCE

25.3

Market Price of Jenburkt Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Jenburkt Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Jenburkt Pharmaceuticals Ltd News Hub

Jenburkt Pharmaceuticals to announce Quarterly Result

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 November

Read more

2024-10-29 00:00:00

Jenburkt Pharmaceuticals standalone net profit rises 31.15% in the September 2024 quarter

Net profit of Jenburkt Pharmaceuticals rose 31.15% to Rs 9.60 crore in the quarter ended September 2

Read more

2024-11-05 00:00:00

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Board of Directors of Jenburkt Pharmaceuticals Ltd

How are members of Jenburkt Pharmaceuticals Ltd Board of Directors selected?

Members of the Jenburkt Pharmaceuticals Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Jenburkt Pharmaceuticals Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.

Can shareholders interact with the Jenburkt Pharmaceuticals Ltd Board of Directors?

Shareholders can interact with the Jenburkt Pharmaceuticals Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.

How often does the Jenburkt Pharmaceuticals Ltd Board of Directors meet?

The Jenburkt Pharmaceuticals Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.

What are the responsibilities of the Jenburkt Pharmaceuticals Ltd Board of Directors?

The Jenburkt Pharmaceuticals Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.

Who are the current members of the Board of Directors at Jenburkt Pharmaceuticals Ltd?

The current Board of Directors at Jenburkt Pharmaceuticals Ltd includes Ashish R Shah( Company Sec. & Compli. Officer) ,Ashish U Bhuta( Chairman & Managing Director) ,Dilip H Bhuta( Whole Time Director & CFO) ,Hina Ravindra Mehta( Non-Exec. & Independent Dir.) ,Sumit Ajaybhai Thakkar( Independent Director) . The full list can be found on Jenburkt Pharmaceuticals Ltd’s official website or recent corporate filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions